Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 202

1.

The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).

Bilyk JR, Murchison AP, Leiby BT, Sergott RC, Eagle RC, Needleman L, Savino PJ.

Trans Am Ophthalmol Soc. 2018 Jun 25;115:T9. eCollection 2017 Aug.

2.

Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes.

Ross AG, Jivraj I, Rodriguez G, Pistilli M, Chen JJ, Sergott RC, Moster M, Sheldon CA, Liu GT, Foroozan R, Ko MW, Francis CE, Williams ZR, Lee AG, McClelland CM, Shindler KS, Yalamanchili S, Osborne B, Hedges TR 3rd, Van Stavern GP, Puckett E, Rigi M, GarcĂ­a-Basterra I, Tamhankar MA.

J Neuroophthalmol. 2018 Apr 24. doi: 10.1097/WNO.0000000000000656. [Epub ahead of print]

PMID:
29697441
3.

Dalfampridine Treatment in Nonarteritic Anterior Ischemic Optic Neuropathy.

Moster ML, Sergott RC, Leiby BE.

J Neuroophthalmol. 2017 Sep;37(3):348-349. doi: 10.1097/WNO.0000000000000523. No abstract available.

PMID:
28538037
4.

EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy.

Birch DG, Benz MS, Miller DM, Antoszyk AN, Markoff J, Kozma P, Meunier E, Sergott RC; OASIS Study Team.

Retina. 2018 Feb;38(2):364-378. doi: 10.1097/IAE.0000000000001536.

5.

Efficacy of Orbital Color Doppler Imaging and Neuroimaging in the Diagnosis of Carotid Cavernous Fistulas.

Srinivasan A, Biro NG, Murchison AP, Sergott RC, Moster ML, Jabbour PM, Bilyk JR.

Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct;33(5):340-344. doi: 10.1097/IOP.0000000000000781.

PMID:
27608286
6.

Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures.

Sergott RC, Johnson CA, Laxer KD, Wechsler RT, Cherny K, Whittle J, Feng G, Lee D, Isojarvi J.

Epilepsia. 2016 Oct;57(10):1634-1642. doi: 10.1111/epi.13495. Epub 2016 Sep 1.

7.

Severe Headache and Blurred Vision.

Finklea BD, Cohen MN, Sergott RC.

JAMA Ophthalmol. 2016 Oct 1;134(10):1191-1192. doi: 10.1001/jamaophthalmol.2016.1295. No abstract available.

PMID:
27533345
8.

Retinal Ganglion Cell and Inner Plexiform Layer Loss Correlate with Visual Acuity Loss in LHON: A Longitudinal, Segmentation OCT Analysis.

Moster SJ, Moster ML, Scannell Bryan M, Sergott RC.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3872-83. doi: 10.1167/iovs.15-17328.

PMID:
27459664
9.

Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry.

Pellock JM, Faught E, Foroozan R, Sergott RC, Shields WD, Ziemann A, Lee D, Dribinsky Y, Torri S, Othman F, Isojarvi J.

Epilepsy Behav. 2016 Jul;60:174-180. doi: 10.1016/j.yebeh.2016.03.030. Epub 2016 May 18.

PMID:
27208827
10.

Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin.

Krauss G, Faught E, Foroozan R, Pellock JM, Sergott RC, Shields WD, Ziemann A, Dribinsky Y, Lee D, Torri S, Othman F, Isojarvi J.

Epilepsy Behav. 2016 Mar;56:15-9. doi: 10.1016/j.yebeh.2015.12.004. Epub 2016 Jan 22.

PMID:
26807550
11.

Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy.

Chen X, Rahimy E, Sergott RC, Nunes RP, Souza EC, Choudhry N, Cutler NE, Houston SK, Munk MR, Fawzi AA, Mehta S, Hubschman JP, Ho AC, Sarraf D.

Am J Ophthalmol. 2015 Jul;160(1):26-34.e1. doi: 10.1016/j.ajo.2015.04.004. Epub 2015 Apr 4.

PMID:
25849522
12.

ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.

Sergott RC, Bennett JL, Rieckmann P, Montalban X, Mikol D, Freudensprung U, Plitz T, van Beek J; ATON Trial Group.

J Neurol Sci. 2015 Apr 15;351(1-2):174-178. doi: 10.1016/j.jns.2015.02.019. Epub 2015 Feb 17.

PMID:
25758472
13.

Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction.

Kaiser PK, Kampik A, Kuppermann BD, Girach A, Rizzo S, Sergott RC.

Retina. 2015 Jun;35(6):1111-27. doi: 10.1097/IAE.0000000000000448.

PMID:
25635577
14.

Tele-ophthalmology screening for proliferative diabetic retinopathy in urban primary care offices: an economic analysis.

Brady CJ, Villanti AC, Gupta OP, Graham MG, Sergott RC.

Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):556-61. doi: 10.3928/23258160-20141118-11.

PMID:
25423636
15.

Re-evaluating the treatment of acute optic neuritis.

Bennett JL, Nickerson M, Costello F, Sergott RC, Calkwood JC, Galetta SL, Balcer LJ, Markowitz CE, Vartanian T, Morrow M, Moster ML, Taylor AW, Pace TW, Frohman T, Frohman EM.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):799-808. doi: 10.1136/jnnp-2014-308185. Epub 2014 Oct 29. Review.

16.

Retinal segmentation using multicolor laser imaging.

Sergott RC.

J Neuroophthalmol. 2014 Sep;34 Suppl:S24-8. doi: 10.1097/WNO.0000000000000164. Review.

PMID:
25133967
17.

The latest on optical coherence tomography.

Sergott RC, Balcer LJ.

J Neuroophthalmol. 2014 Sep;34 Suppl:S1-2. doi: 10.1097/WNO.0000000000000160. No abstract available.

PMID:
25133964
18.
19.

Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.

Shen X, Andrews DW, Sergott RC, Evans JJ, Curran WJ, Machtay M, Fragoso R, Eldredge H, Champ CE, Witek M, Mishra MV, Dicker AP, Werner-Wasik M.

Radiat Oncol. 2012 Dec 28;7:225. doi: 10.1186/1748-717X-7-225.

20.

Gilenya safety update: cardiac and macula.

Huggins A, Sergott RC.

Curr Opin Ophthalmol. 2012 Nov;23(6):457-9. doi: 10.1097/ICU.0b013e3283590bda. No abstract available.

PMID:
23047163

Supplemental Content

Loading ...
Support Center